- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03693053
Socioeconomic Deprivation and Peripheral Arterial Disease (PRECAR)
Assessment of the Level of Precariousness in a Population of Patients With Symptomatic Peripheral Arterial Disease.
Atherosclerosis is a systemic disease that affects coronary, cerebral, and lower-extremity arteries. Peripheral artery disease (PAD) is the manifestation of atherosclerosis in the legs. Three different stages can be found: asymptomatic stage (stage 1), exercise ischemia stage (stage 2) and rest ischemia stage (stage 3). The risk factors for PAD are similar to those for coronary artery disease (CAD) and cerebrovascular disease (CBVD), like high blood pressure, diabetes, smoking, dyslipidemia and obesity. But cigarette smoking is the single most important risk factor for the development and progression of PAD.
PAD is a serious illness and an important predictor of cardiovascular disease with major medico-economic consequences.
A low socioeconomic status (SES) is associated with higher cardiovascular mortality and morbidity. In these vulnerable populations, there is an increase in the prevalence of cardiovascular risk factors, particularly for smoking.
The main objective of this study was to assess the level of precariousness in patients with symptomatic PAD and compare it to the level of precariousness in the general population.
Patients were recruited from vascular medicine and surgery department of Grenoble university hospital or therapeutic education outpatient consultation.
The analysis of socio-economic and environmental data resulted in:
- EPICES score: (Evaluation of the Deprivation and Inequalities of Health in Healthcare Centers score). The EPICES score is a quick and validated questionnaire to assess precariousness at the individual level, developed by considering all the material and psychosocial dimensions of precariousness.
Precariousness, according to the EPICES score, in the general population is estimated at 40%.
- INSEE parameters. The investigators completed the EPICES score with more traditional indicators derived from The National Institute of Statistics and Economic Studies (INSEE) collects, analyses and disseminates information on the French economy and society. The investigators collected the level of education and professional practice based on the nomenclature of socio-professional categories defined by INSEE.
Cardiovascular risk factors were also collected to measure the links between the level of precariousness and cardiovascular risk factors.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Isere
-
Grenoble, Isere, France, 38000
- University Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Patients were recruited from
- Vascular medicine and surgery department of Grenoble university hospital
- Or therapeutic education consultation. These consultations took place in Grenoble reference center of therapeutic education CREPvAL Granted as part of education program: "On the move! Better understand and better live your PAD".
La description
Inclusion Criteria:
- Male or female,
- Age 18 years or older,
- Symptomatic PAD (stage 2 or 3)
Exclusion Criteria:
- Pregnant woman
- Person under administrative or judicial supervision
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Level of precariousness in patients with symptomatic PAD
Délai: one day
|
The level of precariousness is measured by EPICES score : It consists of 11 items related to isolation, health insurance status, economic status, social support and leisure activity.
For each item, a binary response Yes/No is expected from the patient.
The total score ranges from 0 to 100, from lack to the highest social deprivation.
Patients were considered precarious if their score is superior to threshold of 30.
|
one day
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Level of precariousness by EPICES score between stage 2 and stage 3 of symptomatic PAD.
Délai: one day
|
Stade 2 : exercise ischemia stage Stade 3 : rest ischemia stage
|
one day
|
Links between the level of precariousness by EPICES score and cardiovascular risk factors.
Délai: one day
|
Cardiovascular risk factors were: Hypertension was defined as a systolic blood pressure of 140 mm Hg or higher, or a diastolic blood pressure of 90 mm Hg or higher, or current use of antihypertensive drugs. Hypercholesterolemia was defined as LDL cholesterol levels of 0,7 g/l or higher or current use statin. Subjects were considered to have diabetes mellitus if they reported a physician diagnosis of diabetes mellitus, were taking prescription medications for diabetes mellitus (either insulin or oral agents). Subjects were classified into groups of current smokers, former smokers (smoking cessation for more than 9 months) and non-smokers. |
one day
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 38RC17.212
- 2017-A02063-50 (Autre identifiant: ID RCB)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Maladie artérielle périphérique
-
Mayo ClinicInscription sur invitationAnatomie du GSV pour Rescue Peripheral IV AccessÉtats-Unis